HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reversible cysteine protease inhibitors show promise for a Chagas disease cure.

Abstract
The cysteine protease cruzipain is essential for the viability, infectivity, and virulence of Trypanosoma cruzi, the causative agent of Chagas disease. Thus, inhibitors of cruzipain are considered promising anti-T. cruzi chemotherapeutic agents. Reversible cruzipain inhibitors containing a nitrile "warhead" were prepared and demonstrated 50% inhibitory concentrations (IC50s) as potent as 1 nM in baculovirus-generated cruzipain enzyme assays. In epimastigote and intracellular amastigote in vitro assays, the most potent compounds demonstrated antiparasitic behavior in the 5 to 10 μM IC50 range; however, trypomastigote production from the amastigote form was ∼90 to 95% inhibited at 2 μM. Two key compounds, Cz007 and Cz008, with IC50s of 1.1 and 1.8 nM, respectively, against the recombinant enzyme were tested in a murine model of acute T. cruzi infection, with oral dosing in chow for 28 days at doses from 3 to 50 mg/kg of body weight. At 3 mg/kg of Cz007 and 3 mg/kg of Cz008, the blood parasitemia areas under the concentration-time curves were 16% and 25% of the untreated group, respectively. At sacrifice, 24 days after immunosuppression with cyclophosphamide, parasite presence in blood, heart, and esophagus was evaluated. Based on negative quantitative PCR results in all three tissues, cure rates in surviving animals were 90% for Cz007 at 3 mg/kg, 78% for Cz008 at 3 mg/kg, and 71% for benznidazole, the control compound, at 50 mg/kg.
AuthorsMomar Ndao, Christian Beaulieu, W Cameron Black, Elise Isabel, Fabio Vasquez-Camargo, Milli Nath-Chowdhury, Frédéric Massé, Christophe Mellon, Nathalie Methot, Deborah A Nicoll-Griffith
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 58 Issue 2 Pg. 1167-78 ( 2014) ISSN: 1098-6596 [Electronic] United States
PMID24323474 (Publication Type: Journal Article)
Chemical References
  • Cysteine Proteinase Inhibitors
  • Nitroimidazoles
  • Protozoan Proteins
  • Trypanocidal Agents
  • Cysteine Endopeptidases
  • cruzipain
  • benzonidazole
Topics
  • Administration, Oral
  • Animals
  • Area Under Curve
  • Chagas Disease (drug therapy, mortality, parasitology)
  • Cysteine Endopeptidases (metabolism)
  • Cysteine Proteinase Inhibitors (chemical synthesis, pharmacology)
  • Inhibitory Concentration 50
  • Life Cycle Stages (drug effects, physiology)
  • Male
  • Mice
  • Nitroimidazoles (pharmacology)
  • Parasitemia (drug therapy, mortality)
  • Protozoan Proteins (antagonists & inhibitors, metabolism)
  • Survival Analysis
  • Treatment Outcome
  • Trypanocidal Agents (chemical synthesis, pharmacology)
  • Trypanosoma cruzi (drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: